Process for the synthesis of imidazoles

Details for Australian Patent Application No. 2004289685 (hide)

Owner Allergan, Inc.

Inventors Esfandiari, Shervin; Dolby, Lloyd J.; Garst, Michael E.

Agent Davies Collison Cave

Pub. Number AU-A-2004289685

PCT Pub. Number WO2005/047267

Priority 10/706,474 11.11.03 US

Filing date 5 November 2004

Wipo publication date 26 May 2005

International Classifications

C07D 233/54 (2006.01) Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings

C07D 401/04 (2006.01) Heterocyclic compounds containing two or more hetero rings

C07D 409/04 (2006.01) Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms

Event Publications

1 June 2006 PCT application entered the National Phase

  PCT publication WO2005/047267 Priority application(s): WO2005/047267

3 June 2010 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(d). Examination has been requested or an examination report has issued for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2004289690-Benzylether amine compounds useful as CCR-5 antagonists

2004289672-Inhibition of FGFR3 and treatment of multiple myeloma